Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.

Patient-Derived Cancer Xenograft Xebrafish Model (PDXZ) and Personalized Medicine

Proceedings for Annual Meeting of The Japanese Pharmacological Society(2020)10.1254/jpssuppl.93.0_3-o-120Source: DataRank Database

Patient-Derived Cancer Xenograft Xebrafish Model (PDXZ) and Personalized Medicine is a research paper published in Proceedings for Annual Meeting of The Japanese Pharmacological Society (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

0 citations · base score 0

Cite:

datarank_citation_only_1hop_v6· scope data_onlyMethodology

›Data sources & pipeline

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Pending

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

Authors (10)

Itsuko Kuroda,Riho Masukawa,Yuka Mizutani,Aoi Hayasaki,Yasuhiro Murata